Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Chime Financial Insider Sold Shares Worth $1,985,070, According to a Recent SEC Filing

Chime Financial Insider Sold Shares Worth $1,985,070, According to a Recent SEC Filing

MT newswireMT newswire2026/11/06 21:14
05:14 PM EST, 11/06/2026 (MT Newswires) -- Ryan A King, Director, Co-Founder, on November 05, 2026, sold 63,382 shares in Chime Financial (CHYM) for $1,985,070. Following the Form 4 filing with the SEC, King has control over a total of 154,479 Class A common shares of the company, with 116,667 shares held directly and 37,812 controlled indirectly. Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2025. SEC Filing: https://www.sec.gov/Archives/edgar/data/1795586/000206121926000025/xslF345X05/wk-form4_1794002932.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss